Elevated levels of N-terminal pro–B-type natriuretic peptide (NT-proBNP), a key biomarker for diagnosing heart failure, show a nearly fourfold increased risk for atrial fibrillation (AF) in at-risk ...

Please provide your email address to receive an email when new articles are posted on . Cancer survivors with increased NT-proBNP levels had an elevated risk for all-cause and cardiac mortality.

PAH therapies improved hemodynamic parameters and reduced NT-proBNP levels in PH-ILD patients, indicating potential benefits. Precision medicine could help identify PH-ILD patients who may benefit ...

LISBON, Portugal—Patients with suspected de novo heart failure (HF) presenting to outpatient centers are not undergoing echocardiography quickly enough to confirm the HF diagnosis, according to new ...

In a 4.3-year follow-up study, few asymptomatic patients with preclinical left ventricular diastolic dysfunction (LVDD) progressed to heart failure with preserved ejection fraction (HFpEF), with a ...

Scientists develop new blood test to identify individuals at high risk of developing hypertrophic cardiomyopathy, most common ...